Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: Percutaneous needle fasciotomy versus limited fasciectomy

Plastic and Reconstructive Surgery

Volumn 129, Issue 2, 2012, Pages 469-477

  Van Rijssen, Annet L ^a,b   Ter Linden, Hein ^a,b   Werker, Paul M N ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; FASCIA; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE; ORTHOPEDIC SURGERY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TIME;

DUPUYTREN CONTRACTURE; FASCIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEEDLES; ORTHOPEDIC PROCEDURES; RECURRENCE; TIME FACTORS;

EID: 84856703064     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31823aea95     Document Type: Article

References (24)

1. Lermusiaux JL, Debeyre N. Le traitement médical de la maladie de Dupuytren. In: De Séze S, Ryckeawaert A, Kahn M-F, Guérin CI, eds. L'Actualité Rhumatologique. Paris: Expansion Scientifique Française; 1980:338-343.
2. Cline H. Notes on Pathology. London: St Thomas Hospital Medical School Library; 1777.
3. Van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: A 6-week follow-up study. J Hand Surg Am. 2006;31:717-725.
4. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: Complications and results (in French). Chir Main 2001;20:206-211.
5. Van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in Dupuytren's disease. J Hand Surg Br. 2006;31:498-501.
6. Van Rijssen AL, Ter Linden H, Werker PM. Three year results of first-ever randomised clinical trial on treatment in Dupuytren's disease: Percutaneous needle fasciotomy versus limited fasciectomy. In: Charles Eaton M, Seegenschmiedt H, Bayat A, Gabbiani G, Werker P, Wach W, eds. Dupuytren's Disease and Related Hyperproliferative Disorders. Philadelphia: Elsevier (in press).
7. Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: A randomized trial of two skin incisions. J Hand Surg Br. 2005;30:563-566.
8. McFarlane RM, McGrouther DA. Complications and their management. In: McFarlane RM, McGrouther DA, Flint M, eds. Dupuytren's Disease: Biology and Treatment. Edinburgh: Churchill Livingstone; 1990:377-382.
9. Rodrigo JJ, Niebauer JJ, Brown RL, Doyle JR. Treatment of Dupuytren's contracture: Long-term results after fasciotomy and fascial excision. J Bone Joint Surg Am. 1976;58:380-387.
10. Tubiana R. Surgical management. In: Tubiana R, Leclercq C, Hurst LC, Badalamente MA, Mackin EJ, eds. The Hand. Philadelphia: Saunders; 1999:239-250.
11. Coert JH, Nérin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57:13-17.
12. Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture? A prospective, randomised trial. J Bone Joint Surg Br. 2009;91:374-378.
13. Jurisić D, Ković I, Lulić I, Stanec Z, Kapović M, Uravić M. Dupuytren's disease characteristics in Primorsko-goranska County, Croatia. Coll Antropol. 2008;32:1209-1213.
14. Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg Br. 2004;29:427-430.
15. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000;25: 629-636.
16. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002;27:788-798.
17. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767-774.
18. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;36:968-979.
19. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year followup. J Hand Surg Am. 2010;35:534-539, 539.e1.
20. Hueston JT. Current state of treatment of Dupuytren's disease. Ann Chir Main 1984;3:81-92.
21. MäkeläEA, Jaroma H, Harju A, Anttila S, Vainio J. Dupuytren's contracture: The long-term results after day surgery. J Hand Surg Br. 1991;16:272-274.
22. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease: A systematic review. J Hand Surg Eur Vol. 2010;35:623-626.
23. Badois FJ, Lermusiaux JL, Massé C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy (in French). Rev Rhum Ed Fr. 1993;60:808-813.
24. Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31: 1626-1634.